AI assistant
Sending…
ABBOTT LABORATORIES — Director's Dealing 2008
Aug 22, 2008
29777_dirs_2008-08-22_0433a96a-e977-44d5-93db-897ba34ea0cd.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: ABBOTT LABORATORIES (ABT)
CIK: 0000001800
Period of Report: 2008-08-20
Reporting Person: Schumacher Laura J (Executive Vice President)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2008-08-20 | Common shares without par value | M | 8515 | $45.4488 | Acquired | 154584 | Direct |
| 2008-08-20 | Common shares without par value | M | 1213 | $46.19 | Acquired | 155797 | Direct |
| 2008-08-20 | Common shares without par value | F | 8395 | $58.86 | Disposed | 147402 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2008-08-20 | Option (right to buy) | $45.4488 | M | 8515 | Disposed | 2011-02-08 | Common shares (8515) | Direct |
| 2008-08-20 | Option (right to buy) | $46.19 | M | 1213 | Disposed | 2010-02-10 | Common shares (1213) | Direct |
| 2008-08-20 | Option (right to buy) | $58.86 | A | 7340 | Acquired | 2011-02-08 | Common shares (7340) | Direct |
| 2008-08-20 | Option (right to buy) | $58.86 | A | 1055 | Acquired | 2010-02-10 | Common shares (1055) | Direct |
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| Common shares without par value | 5114 | Indirect |
Footnotes
F1: Balance in the Abbott Laboratories Stock Retirement Trust as of August 19, 2008.
F2: Employee stock option granted pursuant to the Abbott Laboratories 1996 Incentive Stock Program, including a replacement option feature, in a transaction exempt from Section 16 under Rule 16b-3.
More from ABBOTT LABORATORIES
Regulatory Filings
2026
Jul 16
Annual Report
2026
Jun 18
Regulatory Filings
2026
May 27
Major Shareholding Notification
2026
Apr 29
Interim / Quarterly Report
2026
Apr 29
Board/Management Information
2026
Apr 27
Regulatory Filings
2026
Apr 24
Legal Proceedings Report
2026
Apr 17
Call Transcript
2026
Apr 16
Earnings Release
2026
Apr 16